Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO)

Clinical trial NCT04968106 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04968106
Sponsor: Institut Bergonié
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Resectable Sarcoma

Start date: 2022-12-07
Primary completion: 2025-08-06
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.